Bavarian Nordic A/S ADR (BVNRY PINK) stock market data APIs
$9.2433
-0.01(-0.1%)
as of March 13, 2026
Try our APIs with
free plan!
Bavarian Nordic A/S ADR Financial Data Overview
Price chart is built with
Anychart
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, England, Finland, Switzerland, Japan, Austria, Italy, Spain, Taiwan, Saudi Arabia, Australia, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Prev. Close
9.2433
Open
9.2334
High
9.2487
Low
9.2307
52 wk Range
6.836-13
Market Cap
2 155 M
P/E Ratio
5.8373
Shares Outstanding
233 M
Revenue
6 244 M
EPS
0.7287
Beta
1.091
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bavarian Nordic A/S ADR data using free add-ons & libraries
Get Bavarian Nordic A/S ADR Fundamental Data
Bavarian Nordic A/S ADR Fundamental data includes:
- Net Revenue: 6 244 M
- EBITDA: 1 654 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bavarian Nordic A/S ADR News
New
Is Bavarian Nordic (CPSE:BAVA) Pricing Reflect Its Vaccine Role And DCF Earnings Signals?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whethe...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Bavarian Nordic A/S COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securitie...
Bavarian Nordic AS (BVNKF) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ...
This article first appeared on GuruFocus. Release Date: March 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Bavarian...
Bavarian Nordic Launches Next Tranche of Share Buy-Back Program
Bavarian Nordic A/S COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the second tranche of the planned buy-back program, under which the Company intends to repur...
Get Bavarian Nordic A/S ADR fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
